1

Country report Austria 1999 for the European network on HIV/AIDS and hepatitis in prisons, European centre for social welfare policy and research, Vienna.

2

Pont J., Auswertung des Fragebogens zu GZ 52201/2-V.4/1996. Bundesministerium für Justiz, 1996 [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998].

3

Drogenfreie Zone im Strafvollzug. Unofficial Report on one year experience with the drug free zone in the Hirtenberg prison.

1

Hariga F., Todts S., Doulou M., Muys M. (2004) Toxicomanie en prison : monitoring des risques sanitaires: une enquête dans 10 prisons belges, SPF Justice Bruxelles.

2

De Maere W. (Free Clinic), Hariga F. (Modus Vivendi), Bartholeyns F. (Université Libre Bruxelles), Vandeverken M. (Université Catholique Louvain). Druggberuik in de gevangenisomgeving. Ontwikkeling van een epidemiologisch onderzoeksinstrusment. Onderzoek uitgevoerd in opdracht van DWTC/SSTC.

3

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

4

Todts S., Fonck K., Colebunders R.,Vercauteren G., Driesen K., Uydebreouck M., Vranckx R., Van Mol F., Tuberculosis, HIV, Hepatitis B and risk behaviour in a Belgian prison, Arch Public Health, 55, 1997, pp 87-98.

1

Generální ředitelství Vězeňské služby ČR (2003) Přehled údajů o užívání drog ve věznicích (Summary of data prepared for the purposes of the Annual Report), Prague: Generální ředitelství vězeňské služby ČR.
Zábranský, T., Radimecký, J., Mravčík, V., Gajdošíková, H., Petroš, O., Korčišová, B., Miovský, M., Vopravil, J., Csémy, L. and Kuda, A.a.N. (2002) Výroční zpráva o stavu ve věcech drog v ČR v r. 2001 (http:/www.drogy-info.cz/filemanager/download/9/ar_2001_Cz_cesky.pdf), Prague: Úřad vlády ČR.

2

Generální ředitelství Vězeňské služby ČR (2003) Ročenka Vězeňské služby ČR 2002 (Annual Report of the Prison Service of the CR), Prague.

1

Kramp P. et Al (2003) Rusmiddelundersogelsen, Misbrug blandt Kriminalforsorgens.

2

Directorate of the Prison and Probation Service, 2002.

1

STAKES and Ministry of Justice (Department of Prison Administration).

2

Ministry of Justice.

3

National Public Health Institute.

1

Mouquet M-C., Dumont M., Bonnevie M-C., La santé à l'entrée en prison : un cumul des facteurs de risque, Études et résultats n°4, Direction de la recherche, des études, de l'évaluation et de la statistique; ministère de l'emploi et de la solidarité, janvier 1999.

2

Rotily M. and Delorme C., L'usage de drogues en milieu carcéral, Drogues et toxicomanies: indicateurs et tendances, OFDT, 1999.

3

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

1

Tielking, K., Becker, S., Stöver, H. (2003). Entwicklung gesundheitsfördernder Angebote im Justizvollzug. (2003). Oldenburg: Bibliotheks- und Informationssystem der Universität Oldenburg.

2

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

3

Kern, Johannes (1997): Zum Ausmaß des Drogenmißbrauchs in den Justizvollzugsanstalten und den Möglichkeiten seiner Eindämmung. Zeitschrift für Strafvollzug und Straffälligenhilfe, 1997 (2), 90-92.

1

Giatroi Choris Sunora. 2001. Katagrafi apotelesmaton diereunisis kai protasi programmatos sti Dikastiki Fulaki Koridallou. Athina: Médecins Sans Frontières.

2

Fotiadou, M., Livaditis, M., Manou, I., Kaniotou, E., Samakouri, M., Tzavaras, N., Xenitidis, K. (2004). Self-reported Substance Misuse in Greek Male Prisoners. European Addiction Research.10:56-60.

3

Aristoteleio Panepistimio Thessalonikis 2000. Diereunisi anagon kai methodon epaggelmatikis katartisis anilikon paravaton kai anilikon se kindino "Orestis" - Leonardo Da Vinci. Thessaloniki (in Greek).

4

Koulierakis G., Gnardelis C., Agrafiotis D. and Power K. (2000) HIV risk behaviour correlates among injecting drug users in Greek prisons. Addictions, 1995, (8), 1207-1216.

5

Malliori M., Sypsa V. Psichogiou M., Touloumi G., Skoutelis A., Tassopoulos N.,Hanzakis A. and Stefanis C. A survey of bloodborne viruses and associate risk behaviours in Greek prisons. Addiction (1998), 93(2), 243-245.

6

Malliori M., Greece, in European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998, pp 114-118.

1

Elekes Zs. And Paksi B., Exploration of risk groups of drug users in imprisoned population, IM.Bv.Op., Research Library for Penalty Authorities 1997/4 (112).

1

Hannon F., Kelleher C., Friel S. (2000) General Healthcare Study of the Irish Prisoner Population, Dublin: Stationery Office.

2

Long J., Allwright S., Barry J., Reaper-Reynolds S., Thornton L., Bradley F. (2000) Hepatitis B, Hepatitis C and HIV in Irish Prisoners, Part II: Prevalence and risk in committal prisoners 1999. Government Publications: Dublin.

3

Allwright, S., Barry, J., Bradley, F., Long, J. and Thornton, L., Hepatitis B, hepatitis C and HIV in Irish prisoners: Prevalence and risk, Dublin: The Stationery Office, 1999.

4

Montjoy Prison Visiting Committee, 1997.

5

O'Mahony P. (1997) Mountjoy Prisoners: A sociological and criminological profile, Department of Justice, Government Publications: Dublin, June 1997.

1

Relazione Annual al Parlamento sullo Stato delle Tossicodipendenze in Italia 2003. Ministero del Lavoro e delle Politiche Sociali. Rome 2004.

2

National survey on drug use and HIV infection amongst prison admissions in 2002, Ministry of Justice, Department for Prison Administration.

3

National survey on drug use and HIV infection amongst prison admissions in 2001, Ministry of Justice, Department for Prison Administration.

4

National survey on drug users and HIV+ among prisoners at 31.12.02, Ministry of Justice.

5

National survey on drug users and HIV+ among prisoners at 31.12.01, Ministry of Justice.

6

National survey on drug users and HIV+ among prisoners at 31.12.00, Ministry of Justice.

7

National survey on drug users and HIV+ among prisoners at 31.12.99, Ministry of Justice.

8

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

1

Snikere S., Trapencieris M., Vanaga S. (2003) 'Survey of Prison Inmates', in Drug abuse Prevalence in Latvia: Population Survey Report, Riga, 71-102.

1

Vladas Kasperunas, Prisons Department under the Ministry of Justice (data not published).

1

Dr Schlink J., Etude épidémiologique des infections par le VIH et l'hépatite virale C dans les prisons luxembourgeoises, CPL, Luxembourg, 2000.

1

Vogelvang B.O., Van Burik A., Van der Knaap L.M., Wartna B.S.J. (2003) Prevalentie van criminogene factoren bij mannelijke gedetineerden in Nederland, Den Haag: Adviesbureau Van Montfoort/WODC.

2

Van Emmerik, J.L., Brouwers, M. De Terbeschikkingstelling in Maat en Getal; Een beschrijving van de tbs-populatie in de periode 1995-2000, Den Haag: Ministerie van Justitie, 2001.

3

Schoemaker C & Zessen G van. Psychische stoornissen bij gedetineerden; Een verkennend onderzoek in Penitentiair Complex Scheveningen. Utrecht, The Netherlands: Trimbos Institute, 1997.

4

Koeter M.W.J. & Luhrman G.C. Verslavingsproblematiek bij justitiabele drugverslaafden, Amsterdam: The Amsterdam Institute for Addiction Research (AIAR), 1998.

5

Bulten, B.H. Gevangen tussen straf en zorg [Caught between punishment and care]. (Doctoral thesis.), Amsterdam: Vrije Universiteit, 1998.

1

Torres A. (coord.) et al., Trajectorias e consumos de drogas nas prisoes: um diagnostico, Lisbon, CIES/ISCTE.

2

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

1

Prison Administration annual report.

1

Evolución terapeutica de previa del drogodependiente que ingresa en 1994. Delegación del Gobierno para el Plan Nacional sobre Drogas en colaboración con la Dirreción General de Instituciones Penitenciarias. Estudio transversal de junio de 1998 sobre sanidad penitenciaria. Dirección General de Instituciones Penitenciarias.

2

Estudio transversal sobre sanidad penitenciaria.

3

Informe de la Comparecencia del Director, General de Instituciones Penitenciarias en el Parlamento, 1999.

4

Miranda MJ., Barberet R., Canteras A., Romero E., Analisis de la eficacia y adecuation de la politica penitenciaria a las necesidades y demandas de las mujeres presas, 1998.

5

Rios JC., Cabrera P., Mil voces Presas, Universidad Pontificia de Comillas, 1998.

6

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

7

Delegacion del Gobierno para el Plan Nacional sobre Drogas/Direccion General de Instituciones Penitenciarias, Evolucion Terapeutica previa del drogodependiente que ingresa en prison, 1994.

1

Kriminalvårdsstyrelsen (2004). Kriminalvårdens redovisning om drogsituationen. Kriminalvårdsstyrelsen, Norrköping (to be published).

2

Weilandt C. and Rotily M., European network on HIV/AIDS and hepatitis prevention in prison: Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998.

1

The differential substance misuse treatment needs of women, ethnic minorities and young offenders in prison: Survey of women (2001).

2

The Criminality Survey, Home Office.

3

Weild A.R., Gill O.N., Bennett D., Livingstone S.J.M., Parry J.V. and Curran L., Prevalence of HIV, hepatitis B, and hepatitis C antibodies in prisoners in England and Wales: a national survey, Communicable Disease and Public Health, vol 3, NO 2, June 2000.

4

Singleton N., Meltzer H., Gatward R. Psychiatric morbidity among prisoners, ONS, Department of Health, London, 1997.

5

Singleton N., Farrel, M. & Meltzer H., Substance misuse among prisoners in England and Wales, London: ONS, 1999.

6

Bellis MA, Weild AR, Beeching NJ, Mutton KJ and Syed Q. Prevalence of HIV and injecting drug use in men entering Liverpool prison. BMJ 1997; 315: 30-31 [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998].

7

Prevalence of HIV in England and Wales in 1995, Annual report of the Unlinked Anonymous Seroprevalence Monitoring Programme in England and Wales, Department of Health, Public Health Laboratory Service, Institute of Child Health, London, 1996 [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998].

8

Bridgwood A. and Malbon G. Survey of the physical health of prisoners [taken from: European network on HIV/AIDS and hepatitis prevention in prison, Annual report to the EC, Marseille/Bonn: ORS/WIAD, 1998].

9

Scottish Prison Service Research Bulletin (2004) Seventh Prison Survey.

10

SPS Research Bulletin 2003 and other forthcoming publications.

11

Bird S.M. and Rotily M. Inside methodologies: for counting blood-borne viruses and injector-inmates' behavioural risks - results from European prisons, The Howard Journal, Vol 41, No. 2, May 2002.

1

Odegard E., Men and women behind the right walls? Drug, alcohol and mental problems among Norwegian inmates (manuscript).

2

Stortingsmelding no.16 (1996-1997) Narkotikapolitikken.